Home › Inflammatory Bowel Disease › New York
Pag-aaral pangklinika para sa Inflammatory Bowel Disease sa New York
21 pag-aaral para sa Inflammatory Bowel Disease ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Ellipsis Research Group, Brooklyn
- Smart Medical Research - Jackson Heights, Jackson Heights
- Pioneer Clinical Research NY, New York
- at 1 pa
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 037, New York
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-002, Albany
- Site US-016, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07845487Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Albany
- Xencor Investigative Site, Rochester
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06619990A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- at 1 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Icahn School of Medicine at Mount Sinai, New York
Nagre-recruitPhase 3
Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04844606A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
- Digestive Disease Medicine of Central New York, Utica
Nagre-recruitPhase 4
3 Weeks · Kababaihan · Na-update Set 8, 2026 · NCT07612267A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05509777Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
- Weill Cornell Medicine, New York
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06274554BOOM-IBD2 Pivotal Clinical Trial
- Northwell Health North Shore University Hospital, Manhasset
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- New York University, New York
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07237516Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore Hutchinson Campus, The Bronx
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06266663Low Dose IL-2 for the Treatment of Crohn's Disease
- Mount Sinai, New York
Nagre-recruitPhase 1/2
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT04263831Autologous Stem Cell Transplant for Crohn's Disease
- Icahn School of Medicine at Mount Sinai, New York
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT03219359Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Cohen Children's Medical Center of NY, Lake Success
- Columbia University Medical Center, New York
Nagre-recruitPhase 4
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update May 27, 2026 · NCT05781152Impact of Morning Light Therapy in IBD
- Mount Sinai Hospital, New York
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT07207200A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, New York
- Mirador Therapeutics Selected Site, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
- NYU Langone Health, New York
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT06309017Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
- Icahn School of Medicine at Mount Sinai, New York
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06001450Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- New York University, New York
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2025 · NCT06750731Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.